Nelson Advisors referenced in NATO Association of Canada article 'Canada’s Need For Binding AI Legislation Amidst Outsourcing Of Canadians Health Data'

NA

Jul 25, 2026By Nelson Advisors

Nelson Advisors has been referenced in the NATO Association of Canada's article 'Canada’s Need For Binding AI Legislation Amidst Outsourcing Of Canadians Health Data'.

Source: https://natoassociation.ca/canadas-need-for-binding-ai-legislation-amidst-outsourcing-of-canadians-health-data/

Canada regards universal healthcare as a national value and a point of sovereign pride, yet the data that powers it (the diagnoses, treatment notes, and intimate clinical conversations recorded by AI scribes etc.) are currently being processed through servers which fall under American law, with no binding Canadian standard for how it is stored or sold. The EU solved this problem with the 2024 AI Act and the 2025 European Health Data Space, but Canada’s answer, fourteen months after Bill C-27 died, is a ministerial task force and a voluntary code of conduct.

Without coordinated action involving regulatory reform and strategic investment, aimed at reducing foreign dependency while building Canadian capability, Canadian medtech investment will leave, and the health AI ecosystem that the country can potentially  own will be built elsewhere. As a result, Canada will not just continue to fall behind in the global technology race, but it will quietly surrender the infrastructure of its own healthcare sovereignty. 

Together, these two frameworks treat infrastructure and governance as a single coordinated act, not as sequential problems to be solved one at a time. The success is measureable, as Europe’s digital health market is currently valued at $96.68 billion and is projected to reach $222.22 billion by 2030. This is growth driven because of binding regulation, not despite it. And these exist as a piece of sovereign infrastructure that Canada has no equivalent of and currently no plan to build. 

https://nelsonadvisors.co.uk/blog/european-healthtech-and-medtech-m-a-predictions-for-2026